Drug details

Lyrica CR (pregabalin extended-release tablets)

type of Anticonvulsants, Other, Fibromyalgia Agents

Lyrica CR (pregabalin) extended-release is an anti-epileptic drug (AED) indicated for the management of neuropathic pain associated with diabetic peripheral neuropathy (DPN) and postherpetic neuralgia (PHN).

The drug is often used to treat Peripheral neuropathy .

This drug may have the following side effects:

• nausea,
• headache,
• blurred vision,
• diarrhea,
• runny or stuffy nose,
• constipation,
• dry mouth,
• drowsiness,
• weight gain,
• fatigue,
• swelling of extremities,
• spinning sensation (vertigo),
• balance problems, 
• dizziness,
• and urinary tract infection (UTI).

The following drugs are related to Lyrica CR, either as a replacement or used together:

• Xcopri (cenobamate tablets)
• Cymbalta (duloxetine hcl)
• Eprontia (topiramate oral solution)
• Lyrica (pregabalin)